Intra-Cellular Therapies
ITCI
#1297
Rank
A$22.20 B
Marketcap
$208.85
Share price
0.01%
Change (1 day)
111.45%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.41

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.56. In 2022 the company made an earnings per share (EPS) of -$4.33 an increase over its 2021 EPS that were of -$5.57.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.41-44.2%
2022-$4.33-22.29%
2021-$5.578.02%
2020-$5.1620.9%
2019-$4.26-5.63%
2018-$4.5233.96%
2017-$3.37-21.19%
2016-$4.28-7.56%
2015-$4.63174.53%
2014-$1.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.40-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$15.91 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.41 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA